Abstract:
Shaping the feed wire for a combustion wire thermal spray process improves the operating capability of the combustion wire gun through higher feed rates and high operating efficiencies. The efficiency of the wire melting is increased over conventional systems through increasing the surface area of the wire cross section and exposing more of the wire material directly to the burner jets.
Abstract:
Shaping the feed wire for a combustion wire thermal spray process improves the operating capability of the combustion wire gun through higher feed rates and high operating efficiencies. The efficiency of the wire melting is increased over conventional systems through increasing the surface area of the wire cross section and exposing more of the wire material directly to the burner jets.
Abstract:
Powder injection apparatus, plasma gun, and method of use. Powder injection apparatus includes a shroud attachable to an outlet nozzle of a thermal spray apparatus and a substantially smooth and continuous inner wall defining a bowl through which a plume of the thermal spray apparatus travels. At least one port in the inner wall is structured and arranged to receive a powder injection nozzle that injects powder into the plume.
Abstract:
Disclosed are compositions and methods for alleviating mucositis, wherein said methods and compositions are directed to the formulation or use of selected nucleoside derivatives, especially ADP-ribose, that conform to the general formula A-B-X and pharmaceutically acceptable salts thereof, wherein “A” is a nucleoside structure selected from adenosine, guanosine, and uridine; “B” is a diphosphate linkage attached to the 5′ carbon of the nucleoside ribose moiety; and “X” is attached to B an is a moiety selected from hydrogen, furanose, or pyranose. Also disclosed are pharmaceuticals and nutritional liquid embodiments thereof, including lozenges, mouthwashes, or other product forms that effectively coat the oral, laryngeal or other mucosal areas. It has been found that these compositions and methods effectively alleviate mucositis in susceptible individuals, especially when administered prior to, during, or after treatments commonly associated with the development of mucositis such as certain chemotherapies, radiation therapies, or combinations thereof.
Abstract:
Thermal spray wire and method of forming thermal spray wire. The thermal spray wire includes an inner layer, a powder material layer surrounding the inner layer, and an outer layer coaxially surrounding and compressing the powder material layer around the inner layer.
Abstract:
A computer system and computer-implemented method for controlling inventory of vendors at one level of a part distribution chain. The system includes a computer programmed with software for generating order data in response to reference data indicative of sales, inventory, demographics, and/or market characteristics of or pertaining to at least two vendors at the same distribution level. The order data is indicative of one or more of a recommended inventory increase transaction (such as a reorder by a vendor of a sold part); an inventory reduction transaction (such as a return of one or more parts in stock at the vendor); and a recommended stocking level of one or more parts by the vendor. When the computer is operated by personnel of a first vendor, it receives reference data concerning at least one other vendor at the same distribution level (in addition to processing reference data concerning the first vendor. When the computer is a host computer, it receives reference data from two or more vendors at the same distribution level. Preferably, the computer which generates the order data is programmed to generate the order data by processing forecast data which is generated by processing the reference data. To generate the forecast data, the computer preferably implements a point-of-sale based method or an actuarial method to determine a forecast of sales of a part by a vendor in a selected time period.
Abstract:
The present invention relates to a thermoformable sheet, for example, an acrylic sheet, comprising particles proximate to the top surface, wherein the textured sheet, when thermoformed, provides a low-gloss, textured surface that is less sensitive to marring, blemishes (including blemishes resulting from the mold), household wear and tear, and visibly reduces the appearance of oil deposits on its surface.
Abstract:
The subject invention relates to monovalent oligosaccharides and their use, for example, in the treatment and prevention of mammalian disease caused by HIV-1 virus infections. In particular, the oligosaccharides globotriose and lactose may be used alone or in combination to competitively inhibit the formation of the viral fusion complex that occurs upon infection.
Abstract:
Acrylic compositions which can be processed into thermoformable acrylic sheet material with variegated non-homogeneous granite appearance are disclosed. The acrylic compositions comprise a matrix of polymethyl methacrylate having dispersed within it particles of a thermoplastic such as polymethyl methacrylate and one or more comonomers wherein the thermoplastic is in the shape of thin wafers 0.05 to 9.53 mm thick, 0.18 to 12.8 wide and 0.18 to 7.62 mm long.
Abstract:
Disclosed are compositions and methods for alleviating mucositis, wherein said methods and compositions are directed to the formulation or use of selected nucleoside derivatives, especially ADP-ribose, that conform to the general formula A-B-X and pharmaceutically acceptable salts thereof, wherein “A” is a nucleoside structure selected from adenosine, guanosine, and uridine; “B” is a diphosphate linkage attached to the 5′ carbon of the nucleoside ribose moiety; and “X” is attached to B an is a moiety selected from hydrogen, furanose, or pyranose. Also disclosed are pharmaceuticals and nutritional liquid embodiments thereof, including lozenges, mouthwashes, or other product forms that effectively coat the oral, laryngeal or other mucosal areas. It has been found that these compositions and methods effectively alleviate mucositis in susceptible individuals, especially when administered prior to, during, or after treatments commonly associated with the development of mucositis such as certain chemotherapies, radiation therapies, or combinations thereof.